Uveitic Glaucoma: Long-term Clinical Outcome and Risk Factors for Progression

被引:15
作者
Sharon, Yael [1 ]
Friling, Ronit [2 ,3 ]
Luski, Moshe [1 ,3 ]
Campoverde, Belen Quizhpe [4 ]
Amer, Radgonde [4 ]
Kramer, Michal [1 ]
机构
[1] Beilinson Med Ctr, Rabin Med Ctr, Dept Ophthalmol, 39 Jabotinsky St, IL-494149 Petah Tiqwa, Israel
[2] Schneider Childrens Med Ctr Israel, Pediat Ophthalmol Unit, Petah Tiqwa, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[4] Hadassah Univ Hosp, Dept Ophthalmol, Jerusalem, Israel
关键词
Clinical outcome; risk factors; secondary glaucoma; uveitis; visual field; ELEVATED INTRAOCULAR-PRESSURE; SECONDARY GLAUCOMA; OCULAR HYPERTENSION; VALVE IMPLANTATION; AHMED GLAUCOMA; PREVALENCE; CHILDREN; TRIAL; EYES;
D O I
10.1080/09273948.2016.1255341
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To study the long-term clinical outcomes of uveitic glaucoma and to identify risk factors for progression. Methods: Retrospective study of uveitic glaucoma patients in two tertiary medical centers in 2003-2015. Patientand disease-related data was retrieved. Clinical parameters and visual fields measured at predetermined time points were recorded. Outcome measures included maintaining intraocular pressure <= 21 mmHg and preserving visual fields. Results: Included were 34 patients (53 eyes), with a mean follow-up of 7 years. Idiopathic anterior uveitis and open-angle glaucoma were most common. In total, 62% of eyes were steroid responders. Higher IOP was associated with posterior synechiae, peripheral-anterior synechiae, steroidal, and immunomodulatory therapy (p<0.05). Glaucomatous field defects developed in 49%, with most showing no progression, despite elevation of cup-to-disc ratio (p<0.05). Conclusions: Chronic severe uveitis, expressed by structural complications and immunomodulatory therapy, was associated with high IOP and the need for more IOP lowering medications, but was unrelated to glaucomatous damage.
引用
收藏
页码:740 / 747
页数:8
相关论文
共 32 条
  • [1] Becker M, 2008, Surgical Management of Inflammatory Eye Disease
  • [2] INTERNATIONAL-UVEITIS-STUDY-GROUP RECOMMENDATIONS FOR THE EVALUATION OF INTRAOCULAR INFLAMMATORY DISEASE
    BLOCHMICHEL, E
    NUSSENBLATT, RB
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1987, 103 (02) : 234 - 235
  • [3] BRAUTBAR C, 1977, J RHEUMATOL, V4, P24
  • [4] Management of uveitic glaucoma with Ahmed glaucoma valve implantation
    Da Mata, A
    Burk, SE
    Netland, PA
    Baltatzis, S
    Christen, W
    Foster, CS
    [J]. OPHTHALMOLOGY, 1999, 106 (11) : 2168 - 2172
  • [5] Human leukocyte antigen distribution in Israeli patients with psoriatic arthritis
    Elkayam, O
    Segal, R
    Caspi, D
    [J]. RHEUMATOLOGY INTERNATIONAL, 2004, 24 (02) : 93 - 97
  • [6] Risk of Elevated Intraocular Pressure and Glaucoma in Patients with Uveitis Results of the Multicenter Uveitis Steroid Treatment Trial
    Friedman, David S.
    Holbrook, Janet T.
    Ansari, Husam
    Alexander, Judith
    Burke, Alyce
    Reed, Susan B.
    Katz, Joanne
    Thorne, Jennifer E.
    Lightman, Susan L.
    Kempen, John H.
    [J]. OPHTHALMOLOGY, 2013, 120 (08) : 1571 - 1579
  • [7] Changes in anterior chamber angle width and depth after intraocular lens implantation in eyes with glaucoma
    Hayashi, K
    Hayashi, H
    Nakao, F
    Hayashi, F
    [J]. OPHTHALMOLOGY, 2000, 107 (04) : 698 - 703
  • [8] Effect of cataract surgery on intraocular pressure control in glaucoma patients
    Hayashi, K
    Hayashi, H
    Nakao, F
    Hayashi, F
    [J]. JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2001, 27 (11) : 1779 - 1786
  • [9] Reduction of intraocular pressure and glaucoma progression - Results from the early manifest glaucoma trial
    Heijl, A
    Leske, MC
    Bengtsson, B
    Hyman, L
    Bengtsson, B
    Hussein, M
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2002, 120 (10) : 1268 - 1279
  • [10] Prevalence of Uveitic Secondary Glaucoma and Success of Nonsurgical Treatment in Adults and Children in a Tertiary Referral Center
    Heinz, Carsten
    Koch, Joerg M.
    Zurek-Imhoff, Beatrix
    Heiligenhaus, Arnd
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2009, 17 (04) : 243 - 248